Worldwide burden of colorectal cancer: a review
- PMID: 27067591
- DOI: 10.1007/s13304-016-0359-y
Worldwide burden of colorectal cancer: a review
Abstract
Colorectal cancer is a major public health problem, being the third most commonly diagnosed cancer and the fourth cause of cancer death worldwide. There is wide variation over time among the different geographic areas due to variable exposure to risk factors, introduction and uptake of screening as well as access to appropriate treatment services. Indeed, a large proportion of the disparities may be attributed to socioeconomic status. Although colorectal cancer continues to be a disease of the developed world, incidence rates have been rising in developing countries. Moreover, the global burden is expected to further increase due to the growth and aging of the population and because of the adoption of westernized behaviors and lifestyle. Colorectal cancer screening has been proven to greatly reduce mortality rates that have declined in many longstanding as well as newly economically developed countries. Statistics on colorectal cancer occurrence are essential to develop targeted strategies that could alleviate the burden of the disease. The aim of this paper is to provide a review of incidence, mortality and survival rates for colorectal cancer as well as their geographic variations and temporal trends.
Keywords: Colorectal cancer; Epidemiology; Incidence; Mortality.
Similar articles
-
Strategies and resources to address colorectal cancer screening rates and disparities in the United States and globally.Annu Rev Public Health. 2013;34:413-29. doi: 10.1146/annurev-publhealth-031912-114436. Epub 2013 Jan 7. Annu Rev Public Health. 2013. PMID: 23297661 Review.
-
Worldwide variations in colorectal cancer.CA Cancer J Clin. 2009 Nov-Dec;59(6):366-78. doi: 10.3322/caac.20038. CA Cancer J Clin. 2009. PMID: 19897840 Review.
-
The Rise of Colorectal Cancer in Asia: Epidemiology, Screening, and Management.Curr Gastroenterol Rep. 2019 Jul 10;21(8):36. doi: 10.1007/s11894-019-0703-8. Curr Gastroenterol Rep. 2019. PMID: 31289917 Review.
-
Colorectal cancer screening: a global overview of existing programmes.Gut. 2015 Oct;64(10):1637-49. doi: 10.1136/gutjnl-2014-309086. Epub 2015 Jun 3. Gut. 2015. PMID: 26041752 Review.
-
Colorectal cancer-global burden, trends, and geographical variations.J Surg Oncol. 2017 Apr;115(5):619-630. doi: 10.1002/jso.24578. Epub 2017 Feb 13. J Surg Oncol. 2017. PMID: 28194798
Cited by
-
Identification of key gene modules and genes in colorectal cancer by co-expression analysis weighted gene co-expression network analysis.Biosci Rep. 2020 Sep 30;40(9):BSR20202044. doi: 10.1042/BSR20202044. Biosci Rep. 2020. PMID: 32815531 Free PMC article.
-
TLR4, IgA and EpCAM Expression in Colorectal Cancer and Their Possible Association with Microbiota as a Pathogenic Factor; An Immunohistochemical and Genetic Study.Asian Pac J Cancer Prev. 2024 Feb 1;25(2):627-636. doi: 10.31557/APJCP.2024.25.2.627. Asian Pac J Cancer Prev. 2024. PMID: 38415550 Free PMC article.
-
Estimating Risk of Cardiovascular Disease Among Long-Term Colorectal Cancer Survivors: A Nationwide Cohort Study.Front Cardiovasc Med. 2022 Jan 17;8:721107. doi: 10.3389/fcvm.2021.721107. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35111822 Free PMC article.
-
Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.Comput Math Methods Med. 2022 Jan 25;2022:1709918. doi: 10.1155/2022/1709918. eCollection 2022. Comput Math Methods Med. 2022. PMID: 35116071 Free PMC article.
-
A comprehensive review on RNA interference-mediated targeting of interleukins and its potential therapeutic implications in colon cancer.3 Biotech. 2023 Jan;13(1):18. doi: 10.1007/s13205-022-03421-x. Epub 2022 Dec 20. 3 Biotech. 2023. PMID: 36568500 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical